Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
British Journal of Clinical Pharmacology
|
June 26, 2014
Covariate selection in pharmacometric analyses: a review of methods
Matthew M Hutmacher, Kenneth G Kowalski
Journal of Pharmacokinetics and Pharmacodynamics
|
November 12, 2009
Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder
Bill Frame, Raymond Miller, Matthew M Hutmacher
British Journal of Anaesthesia
|
October 1, 1991
Fresh gas utilization of eight circle systems
A M Zbinden, P Feigenwinter, M Hutmacher
Journal of Pharmacokinetics and Pharmacodynamics
|
September 20, 2012
Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database
K Ito, M M Hutmacher, B W Corrigan
Journal of Pharmacokinetics and Pharmacodynamics
|
December 7, 2007
Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients
Matthew M Hutmacher, Sriram Krishnaswami, Kenneth G Kowalski
Journal of Pharmacokinetics and Pharmacodynamics
|
February 27, 2008
An alternative method for population pharmacokinetic data analysis under noncompliance
Pankaj Gupta, Matthew M Hutmacher, Bill Frame, et al.
Statistics in Medicine
|
April 8, 2011
Estimating transformations for repeated measures modeling of continuous bounded outcome data
Matthew M Hutmacher, Jonathan L French, Sriram Krishnaswami, et al.
Journal of Clinical Pharmacology
|
January 25, 2007
Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis
Matthew M Hutmacher, Ivan Nestorov, Tom Ludden, et al.
Journal of Clinical Pharmacology
|
June 16, 2015
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain
Matthew M Hutmacher, Bill Frame, Raymond Miller, et al.
Clinical Pharmacology and Therapeutics
|
September 21, 2007
Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain
K G Kowalski, S Olson, A E Remmers, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
British Journal of Clinical Pharmacology
|
June 26, 2014
Covariate selection in pharmacometric analyses: a review of methods
Matthew M Hutmacher, Kenneth G Kowalski
Journal of Pharmacokinetics and Pharmacodynamics
|
November 12, 2009
Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder
Bill Frame, Raymond Miller, Matthew M Hutmacher
British Journal of Anaesthesia
|
October 1, 1991
Fresh gas utilization of eight circle systems
A M Zbinden, P Feigenwinter, M Hutmacher
Journal of Pharmacokinetics and Pharmacodynamics
|
September 20, 2012
Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database
K Ito, M M Hutmacher, B W Corrigan
Journal of Pharmacokinetics and Pharmacodynamics
|
December 7, 2007
Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients
Matthew M Hutmacher, Sriram Krishnaswami, Kenneth G Kowalski
Journal of Pharmacokinetics and Pharmacodynamics
|
February 27, 2008
An alternative method for population pharmacokinetic data analysis under noncompliance
Pankaj Gupta, Matthew M Hutmacher, Bill Frame, et al.
Statistics in Medicine
|
April 8, 2011
Estimating transformations for repeated measures modeling of continuous bounded outcome data
Matthew M Hutmacher, Jonathan L French, Sriram Krishnaswami, et al.
Journal of Clinical Pharmacology
|
January 25, 2007
Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis
Matthew M Hutmacher, Ivan Nestorov, Tom Ludden, et al.
Journal of Clinical Pharmacology
|
June 16, 2015
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain
Matthew M Hutmacher, Bill Frame, Raymond Miller, et al.
Clinical Pharmacology and Therapeutics
|
September 21, 2007
Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain
K G Kowalski, S Olson, A E Remmers, et al.
Page
of 4